Osteoblasts-derived TGF-β1 enhance motility and integrin upregulation through Akt, ERK, and NF-κB-dependent pathway in human breast cancer cells

Molecular Carcinogenesis

Volumn 47, Issue 7, 2008, Pages 526-537

  Wei, Ying Ying ^a   Chen, Ying Ju ^a   Hsiao, Yu Chun ^a   Huang, Yi Chia ^a   Lai, Tzu Hsu ^a   Tang, Chih Hsin ^a,b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Breast cancer; Integrin; Migration; Osteoblasts; TGF 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; BETA1 INTEGRIN; BETA3 INTEGRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; INTEGRIN; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; PROTEIN KINASE B; PYRROLIDINE DITHIOCARBAMATE; SMALL INTERFERING RNA; SYNAPTOTAGMIN I; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRANSFORMING GROWTH FACTOR BETA1; I KAPPA B; I KAPPA B KINASE; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL MIGRATION; CELL MOTILITY; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; ANIMAL; BREAST TUMOR; CELL CULTURE; CELL MOTION; CULTURE MEDIUM; DRUG ANTAGONISM; FLOW CYTOMETRY; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

MAMMALIA;

ANIMALS; ANTIGENS, CD29; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL MOVEMENT; CULTURE MEDIA, CONDITIONED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; INTEGRIN BETA3; LUCIFERASES; MICE; NF-KAPPA B; OSTEOBLASTS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 45949095352     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20411     Document Type: Article

References (44)

1. Van't Veer LJ, Weigelt B. Road map to metastasis. Nat Med 2003;9:999-1000.
2. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
3. Mundy GR. Metastasis to bone: Causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002;2:584-593.
4. Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer 1997;80:1529-1537.
5. Humphries MJ. Integrin structure. Biochem Soc Trans 2000; 28:311-339.
6. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999; 285:1028-1032.
7. Brooks PC, Montgomery AM, Rosenfeld M, et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994; 79:1157-1164.
8. Brooks PC, Stromblad S, Klemke R, et al. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 1995;96:1815-1822.
9. Albelda SM, Mette SA, Elder DE, et al. Integrin distribution in malignant melanoma: Association of the beta 3 subunit with tumor progression. Cancer Res 1990;50:6757-6764.
10. Hieken TJ, Farolan M, Ronan SG, et al. Beta3 integrin expression in melanoma predicts subsequent metastasis. J Surg Res 1996;63:169-173.
11. Pecheur I, Peyruchaud O, Serre CM, et al. Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone. FASEB J 2002;16:1266-1268.
12. Cooper CR, Chay CH, Pienta KJ. The role of alpha(v)beta(3) in prostate cancer progression. Neoplasia 2002;4:191-194.
13. Kumar CC. Integrin alpha v beta 3 as a therapeutic target for blocking tumor-induced angiogenesis. Curr Drug Targets 2003;4:123-131.
14. Wang X, Ferreira AM, Shao Q, et al. Beta3 integrins facilitate matrix interactions during transendothelial migration of PC3 prostate tumor cells. Prostate 2005;63:65-80.
15. Taichman RS, Cooper C, Keller ET, et al. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002;62:1832-1837.
16. Massague J. TGF-β signal transduction. Annu Rev Biochem 1998;67:753-791.
17. Robert AB. TGF- β signaling from receptors to the nucleus. Microbes Infect 1999;1:1265-1273.
18. Leivonen SK, Kahari VM. Transforming growth factor-beta signaling in cancer invasion and metastasis. Int J Cancer 2007;121:2119-2124.
19. Chu CY, Cha ST, Chang CC, et al. Involvement of matrix metalloproteinase-13 in stromal-cell-derived factor 1alpha-directed invasion of human basal cell carcinoma cells. Oncogene 2007;26:2491-2501.
20. Tang CH, Yang RS, Huang TH, et al. Ultrasound stimulates cyclooxygenase-2 expression and increases bone formation through integrin, focal adhesion kinase, phosphatidylinositol 3-kinase, and Akt pathway in osteoblasts. Mol Pharmacol 2006;69:2047-2057.
21. Tang CH, Yang RS, Fu WM. Prostaglandin E2 stimulates fibronectin expression through EP1 receptor, phospholipase C, protein kinase C alpha, and c-Src pathway in primary cultured rat osteoblasts. J Biol Chem 2005;280:22907-22916.
22. Centrella M, Casinghino S, McCarthy TL. Differential actions of prostaglandins in separate cell populations from fetal rat bone. Endocrinology 1994;135:1611-1620.
23. Siri S, Chen MJ, Chen TT. Biological activity of rainbow trout Ea4-peptide of the pro-insulin-like growth factor (pro-IGF)-I on promoting attachment of breast cancer cells (MDA-MB-231) via alpha2- and beta1-integrin. J Cell Biochem 2006; 99:1524-1535.
24. Zhao Y, Bachelier R, Treilleux I, et al. Tumor alpha v beta3 integrin is a therapeutic target for breast cancer bone metastases. Cancer Res 2007;67:5821-5830.
25. Liu H, Radisky DC, Nelson CM, et al. Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for T SC2. Proc Natl Acad Sci USA 2006;103: 4134-4139.
26. Amiri A, Noei F, Jeganathan S, et al. eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration. Oncogene 2007;26:3027-3040.
27. Sebolt-Leopold JS, Herrera R. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 2004;4:937-947.
28. Boukerche H, Su ZZ, Emdad L, et al. Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB. Cancer Res 2007;67:1812-1822.
29. Madrid LV, Mayo MW, Reuther JY, et al. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 2001;276:18934-18940.
30. Viatour P, Merville MP, Bours V, et al. Phosphorylation of NF-kappaB and IkappaB proteins: Implications in cancer and inflammation. Trends Biochem Sci 2005;30: 43-52.
31. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics. CA Cancer J Clin 2001;51:15-36.
32. Mundy GR. Metastasis to bone: Causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002;2:584-593.
33. Mundy GR, Yoneda T. Facilitation and suppression of bone metastasis. Clin Orthop Relat Res 1995;312:34-44.
34. Kakonen SM, Mundy GR. Mechanisms of osteolytic bone metastases in breast carcinoma. Cancer 2003;97:834-839.
35. Mundy GR, Yoneda T. Facilitation and suppression of bone metastasis. Clin Orthop Relat Res 1995;312:34-44.
36. Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura RA. Bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 2001;16:1486-1495.
37. Miranti CK, Brugge JS. Sensing the environment: A historical perspective on integrin signal transduction. Nat Cell Biol 2002;4:E83-E90.
38. Hynes RO. Integrins: Bidirectional, allosteric signaling machines. Cell 2002;110:673-687.
39. Katiyar SK, Meeran SM. Obesity increases the risk of UV radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling. Free Radic Biol Med 2007;42:299-310.
40. Levy Y, Ronen D, Bershadsky AD, Zick Y. Sustained induction of ERK, protein kinase B, and p70 S6 kinase regulates cell spreading and formation of F-actin microspikes upon ligation of integrins by galectin-8, a mammalian lectin. J Biol Chem 2003;278:14533-14542.
41. Matsuo M, Sakurai H, Ueno Y, et al. Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin alphav-mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib. Cancer Sci 2006;97: 155-162.
42. Vermeulen G, De Wilde P, Van Damme W, Haegeman G. Transcriptional activation of the NF-κB p65 subunit by mitogen- and stress-activated protein kinase-1. EMBO J 2003;22:1313-1324.
43. Zhong H, Su H, Yang H, et al. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 1997; 89:413-424.
44. Sakurai H, Chiba H, Miyoshi T, Sugita W. IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 1999;274:30353-30356.